Nuveen Churchill Direct Lending Corp. quarterly report, Q2 FY2023

Business context and reporting period

Nuveen Churchill Direct Lending Corp. is an externally managed business development company (BDC) that invests primarily in senior-secured loans to U.S. middle-market companies. This unaudited Form 10-Q covers the quarter and six months ended June 30, 2023. Its shares were not listed on an exchange; the company completed its final private-offering closing on April 28, 2023.

Key financial metrics

  • Second-quarter 2023: Investment income was $37.1 million, up from $16.5 million a year earlier. Net investment income (NII) was $18.3 million ($0.60 per share), versus $9.7 million ($0.44 per share). Net realized and unrealized investment losses totaled $4.0 million, compared with losses of $12.5 million; net increase in net assets from operations was $14.3 million, versus a $2.7 million decrease.
  • First half 2023: Investment income was $71.1 million, versus $30.6 million; NII was $35.7 million ($1.20 per share), versus $18.8 million. Net realized gains were $6.7 million, while unrealized depreciation was $15.4 million, resulting in net investment losses of $8.7 million and net increase in net assets from operations of $27.0 million, versus $4.0 million a year earlier.
  • Margins and costs: NII was about 49% of investment income in Q2 2023, versus 59% in Q2 2022. Interest and debt financing expense rose to $14.3 million for the quarter and $27.0 million for the half year, from $4.2 million and $7.3 million, respectively. Management attributed the increase to higher borrowings and rates, as well as the 2022 securitization.
  • Portfolio and NAV: Investment fair value was $1.351 billion at June 30, compared with $1.200 billion at December 31, 2022. Net assets were $557.5 million; NAV was $17.93 per share, down from $18.32 at year-end. First-lien loans represented 86.7% of investment fair value; subordinated debt 11.5% and equity 1.8%. The weighted-average yield on debt and income-producing investments at cost was 11.37%, up from 10.61% at year-end.
  • Cash flow and liquidity: Cash and cash equivalents were $45.4 million. For the six months, operating activities used $120.5 million, largely reflecting investment purchases; financing activities provided $126.7 million, and cash increased $6.2 million. The company reported $247.5 million of available borrowing capacity and $320.9 million of undrawn shareholder commitments. Unfunded loan commitments were $114.7 million.
  • Debt: Gross debt outstanding was $825.4 million ($818.6 million net of deferred financing costs on the balance sheet), up from $705.4 million gross at year-end. Asset coverage was 167.54%, above the 150% statutory minimum but down from 174.41%. Average borrowing rates were 7.17% in Q2 and 6.97% for the first half, versus 3.00% and 2.86% in the comparable 2022 periods.
  • Distributions: The company declared $1.10 per share from investment income and $0.21 per share from realized gains during the first half. The June declaration included a $0.50 regular distribution and a $0.05 supplemental distribution per share.

Material changes versus comparable periods

  • Income rose substantially as the portfolio expanded and floating benchmark rates increased; the portfolio’s weighted-average yield at cost rose from 8.11% at June 30, 2022 to 11.37% at June 30, 2023.
  • Financing costs increased sharply alongside higher average borrowings and rates. Despite higher NII, the first-half unrealized loss was $15.4 million, leaving the increase in net assets from operations at $27.0 million.
  • Portfolio companies increased from 145 at year-end 2022 to 161 at June 30, 2023. Investment fair value grew, while NAV per share declined from $18.32 to $17.93.
  • Credit ratings show some deterioration: 7.64% of portfolio fair value was rated “Performing—Management Notice” (rating 5), and 1.52% was on the watch list at rating 7. Two companies, representing $4.7 million fair value, were rated probable loss; loans on non-accrual were 0.34% of portfolio fair value, down from 0.74% at year-end.

Outlook, risks and unusual items

  • Management said it had not observed broad portfolio deterioration, but cited recession risk, inflation, supply-chain and labor pressures, geopolitical instability, banking-system strain, and headwinds in financing and M&A markets. It is monitoring vulnerable credits and says it intends to favor defensive businesses with strong free cash flow.
  • Interest-rate movements affect both floating-rate portfolio income and floating-rate borrowing costs. Approximately 94.55% of debt investments were floating-rate; the filing estimates a 100-basis-point rate increase would raise annual net income by $2.3 million, while a 100-basis-point decrease would reduce it by the same amount, based on the portfolio and debt outstanding at June 30.
  • Valuation is a key risk: most investments are Level 3, based on significant unobservable inputs, and realized proceeds could differ materially from reported fair values. The Adviser became the board-designated valuation designee effective in Q1 2023, subject to board oversight.
  • Nearly all LIBOR-referenced loans had been amended to alternative rates, primarily CME Term SOFR. The filing warns that replacement benchmarks may not produce equivalent economics and may introduce pricing or liquidity risk.
  • A new senior secured revolving facility was entered into on June 23, with an initial maximum of $185 million and potential accordion capacity to $300 million; it had no borrowings at quarter-end. The $35 million subscription facility outstanding matures September 8, 2023, and the SMBC facility’s draw period is scheduled to end November 24, 2023.
  • After quarter-end, 4,357,515 shares were issued on July 17 for approximately $78.6 million. Management reported no material legal proceedings and no defaults on senior securities.

Important facts for investors to verify

  • How much of the portfolio’s fair-value depreciation reflects borrower-specific credit deterioration versus market pricing, and how might that affect NAV?
  • Whether NII and distributions remain adequately supported after higher borrowing costs, and how the near-term facility maturities and draw-period deadlines will be managed.
  • Current watch-list exposures, non-accrual trends, and the repayment prospects for positions identified as probable loss.
  • Availability and terms of undrawn credit capacity and shareholder commitments, including any borrowing-base or covenant restrictions.
  • How the post-quarter $78.6 million share issuance affects shares outstanding, NAV per share, and investment capacity.